Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment
NCT00133276
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Interventions
DRUG:
Escitalopram
OTHER:
Placebo
Sponsor
Foundation for Liver Research